v3.25.4
Condensed Consolidated Balance Sheets (Unaudited) - USD ($)
Dec. 31, 2025
Sep. 30, 2025
Current Assets:    
Cash and cash equivalents $ 7,295,451 $ 3,924,908
Accounts receivable, net of allowances 4,049,111
Inventory 22,639,342 22,286,693
Prepaid expenses 3,162,940 1,331,280
Total Current Assets 37,146,844 27,542,881
Other Assets:    
In-process research and development, net of accumulated amortization 72,826,562 73,400,000
Total Other Assets 72,826,562 73,400,000
Total Assets 109,973,406 100,942,881
Current Liabilities:    
Accounts payable 10,446,900 13,234,684
License payable 18,250,000 22,650,000
Accrued expenses 4,518,916 4,093,124
Total Current Liabilities 44,710,394 49,491,579
Deferred tax liability 3,049,200 2,784,960
Total Liabilities 51,559,705 56,076,650
Stockholders’ Equity:    
Preferred stock - $0.0001 par value; 10,000,000 shares authorized: no shares issued and outstanding
Common stock - $0.0001 par value; 400,000,000 shares authorized at December 31, 2025 and September 30, 2025; 84,797,846 and 83,513,442 shares issued and outstanding at December 31, 2025 and September 30, 2025, respectively 8,480 8,351
Additional paid-in capital 127,979,246 108,897,836
Accumulated deficit (69,574,025) (64,039,956)
Total Stockholders’ Equity 58,413,701 44,866,231
Total Liabilities and Stockholders’ Equity 109,973,406 100,942,881
Related Party    
Current Liabilities:    
Due to related party 11,494,578 9,513,771
Note payable to related party $ 3,800,111 $ 3,800,111